Status:
UNKNOWN
Study on the Relationship Between Neutrophil-mediated Thrombocytopenia and the Condition and the Course of Disease in Patients With HFRS
Lead Sponsor:
First Affiliated Hospital Xi'an Jiaotong University
Conditions:
Hemorrhagic Fever With Renal Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Thrombocytopenia is an important pathological feature of HFRS（Hemorrhagic Fever With Renal Syndrome, HFRS）. However, the cause of thrombocytopenia in HFRS is not yet fully understood. Neutrophils, as ...
Eligibility Criteria
Inclusion
- Age ≥18 years;
- Clinical diagnosis meets the diagnostic criteria of the national HFRS prevention and treatment plan (Hantavirus-specific IgM antibody is positive). The classification and staging standards of HFRS patients are based on the "Expert Consensus of Shaanxi Province on Diagnosis and Treatment of Hemorrhagic Fever with Renal Syndrome".
Exclusion
- Age \<18 years;
- Have a history of kidney disease;
- Have a history of liver disease;
- Have a history of malignant tumor;
- Receive dialysis treatment before admission;
- Combined with hypertension, coronary heart disease and diabetes history;
- Combined with HIV infection and patients with autoimmune diseases and pregnancy.
Key Trial Info
Start Date :
October 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2024
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT04834713
Start Date
October 9 2020
End Date
February 28 2024
Last Update
September 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Affiliated Hospital of Xian Jiaotong university
Xi'an, Shaanxi, China, 710061